Press Mistakes
Jerry Kindall was recently upset to read a major mistake in Forbes magazine regarding selective serotonin reuptake inhibitors (SSRIs) and other antidepressant medications. He's right that it was a pretty major mistake, and should leave us rightly suspicious of the reporting at Forbes--although I'm not sure this is any worse than mistakes on scientific and medical issues I've seen in other newspapers and magazines.
Forbes might have messed up on this one, but in general, I find it to be pretty reliable, and much better written IMHO than either Forbes or Business Week.
People should remember that business journalists are generally not biomedical experts, electronics experts, or whatever. No one should be buying stocks based on a single magazine article or TV mention. Prowl around the industry a bit and find out what is going on. Look at the competitors of the company you are thinking about investing in, and see how *they* view the world.
I would say that I was "dismayed" rather than "upset."
They did get a sound bite from a professor of psychiatry for the article, but I can hardly believe he only gave them seventeen useful words.